KOPRAN LTD
KOPRAN · General/Diversified · NSE
₹160
Current Market Price
Under Review— We don’t have enough data to publish a fair value estimate for KOPRAN yet. Reason: Data Limited.
Updated just now
YieldIQ Score
—
Piotroski F-Score
6/9
Economic Moat
None
Confidence
29%
ROE
4.9%
Debt/Equity
0.29
WACC
11.1%
Market Cap
₹771.41 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
9.1%
Return on capital employed
EV / EBITDA
13.4×
Enterprise multiple
Debt / EBITDA
2.0×
Leverage vs earnings
Interest Coverage
7.7×
EBIT covers interest
Current Ratio
1.76×
Short-term liquidity
Asset Turnover
0.73×
Revenue per ₹ of assets
Revenue CAGR (3Y)
7.5%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
Ratio Trends
KOPRAN · last 10 annual periods
ROE
4.9%
ROCE
9.1%
Operating Margin
—
Debt / Equity
0.29×
PE
19.6×
EV / EBITDA
11.3×
Historical Financials
KOPRAN · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹474 Cr | ₹548 Cr | ₹615 Cr | ₹630 Cr | ₹681 Cr | +9.5% |
| EBITDA | ₹96.5 Cr | ₹53.3 Cr | ₹86.8 Cr | ₹76.9 Cr | ₹62.3 Cr | -10.4% |
| EBIT | ₹86.9 Cr | ₹42.1 Cr | ₹76.1 Cr | — | — | -3.3% |
| PAT | ₹61.0 Cr | ₹27.2 Cr | ₹51.0 Cr | ₹38.6 Cr | ₹25.7 Cr | -19.4% |
| EPS (diluted) | ₹13.77 | ₹5.65 | ₹10.55 | — | — | -6.4% |
| CFO | ₹-33.5 Cr | ₹34.0 Cr | ₹43.3 Cr | ₹41.9 Cr | ₹66.8 Cr | — |
| CapEx | ₹-42.3 Cr | ₹-61.0 Cr | ₹-56.6 Cr | ₹-58.9 Cr | ₹-67.1 Cr | — |
| FCF | ₹-75.7 Cr | ₹-27.0 Cr | ₹-13.4 Cr | ₹-17.0 Cr | ₹-0.4 Cr | — |
| Total Assets | ₹611 Cr | ₹650 Cr | ₹743 Cr | ₹844 Cr | ₹908 Cr | +10.4% |
| Total Debt | ₹72.5 Cr | ₹75.2 Cr | ₹99.2 Cr | ₹148 Cr | ₹153 Cr | +20.5% |
| Shareholders' Equity | ₹426 Cr | ₹439 Cr | ₹491 Cr | ₹518 Cr | ₹530 Cr | +5.6% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
KOPRAN vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
AHCL ANLON HEALTHCARE LIMITED | -31.6% | 50 | Above Fair Value | 25.5% | — |
MAXIND MAX INDIA LIMITED | -100.0% | 35 | Data Limited | -39.1% | — |
 TAKE TAKE | — | — | Pending | — | — |
ANUHPHR ANUHPHR | — | — | Pending | 11.7% | — |
 THEMISMED THEMISMED | — | — | Pending | 7.4% | — |
Click a ticker to view its fair-value analysis.
Dividend History
6 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹13.50/sh
Last payout
2025-09-04
₹3.00
Peak payout
₹3.00
Trailing yield
1.88%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
Risk Analysis
Volatility & drawdown
Risk profile of KOPRAN →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for KOPRAN →
Compare
Head-to-head with peers
Compare KOPRAN side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse KOPRANNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.